RecruitingPhase 1 / Phase 2NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Sponsor: Parabilis Medicines, Inc.
New Haven, CT · +30 more sites
Prostate Cancer clinical trials in New Haven, CT
17 recruiting prostate cancer studies with a site in New Haven, CT.
RecruitingPhase 1NCT05800665
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Sponsor: Genentech, Inc.
New Haven, CT · +4 more sites
RecruitingPhase 2NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Sponsor: Daiichi Sankyo
New Haven, CT · +12 more sites
RecruitingPhase 1 / Phase 2NCT06800313
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Sponsor: Janssen Research & Development, LLC
New Haven, CT · +16 more sites
RecruitingPhase 1NCT05983432
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Sponsor: SystImmune Inc.
New Haven, CT · +21 more sites
RecruitingPhase 1NCT07080242
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
Sponsor: SystImmune Inc.
New Haven, CT · +23 more sites
RecruitingPhase 2NCT06111781
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
Sponsor: Yale University
New Haven, CT · +3 more sites
RecruitingPhase 1NCT06458712
Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
Sponsor: Duke Street Bio Ltd
New Haven, CT · +3 more sites
RecruitingPhase 1NCT04221542
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Amgen
New Haven, CT · +24 more sites
RecruitingPhase 2NCT06842498
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Sponsor: Kyntra Bio
New Haven, CT · +22 more sites
RecruitingPhase 1 / Phase 2NCT03972657
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Sponsor: Regeneron Pharmaceuticals
New Haven, CT · +23 more sites
RecruitingPhase 1 / Phase 2NCT06457919
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
New Haven, CT · +11 more sites
RecruitingPhase 1 / Phase 2NCT07258407
A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer
Sponsor: T.O.A.D. Oncology SA
New Haven, CT
RecruitingPhase 2NCT04606446
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Sponsor: Pfizer
New Haven, CT · +20 more sites
RecruitingPhase 1 / Phase 2NCT06395519
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Sponsor: 858 Therapeutics, Inc.
New Haven, CT · +13 more sites
RecruitingPhase 4NCT04373564
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Sponsor: Guerbet
New Haven, CT · +15 more sites
Not yet recruitingNot applicableNCT07746414
Effects of Exercise Prior to Radical Prostatectomy
Sponsor: Yale University
New Haven, CT
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.